Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids

Author(s):  Glasnapp Andrew

Issue:  Sep/Oct 1999 - Natural Hormone Replacement Therapy
View All Articles in Issue

Page(s):  380-381

Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Page 1
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Page 2

Download in electronic PDF format for $75

Abstract:  Keloid scar formation is a significant problem affecting millions of patients annually. Proposed management or prevention of keloids includes three distinctly different therapeutic approaches: correction of abnormal collagen metabolism when the equilibrium between collagen synthesis and degradation has been destroyed, alteration of the immune/inflammatory response and manipulation of the mechanical properties of wound repair. There currently is no universally accepted treatment modality resulting in permanent keloid scar ablation. The author discusses the pathology of keloids and tamoxifen citrate (efficacy and description). He also provides a Formula for Tamoxifen Citrate Cream 0.1% (100 g).

Related Keywords: collagen, fibrosis, hypertrophic scar, keloids, tamoxifen citrate, wound repair

Related Categories: CANCER AND AIDS, DERMATOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids
Glasnapp Andrew
Sep/Oct 1999
Pg. 380-381

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Options in Wound Care
Kincaid Michele R
Mar/Apr 2002
Pg. 92-95

Tamoxifen Citrate Cream 0.1%
Allen Loyd V Jr
Sep/Oct 1999
Pg. 381

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson
, Carvalho Maria, Banov Fabiana
May/Jun 2018
Pg. 182-188

Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 240

Head to Toe Solutions: A Quick Review of Current Therapies
Paoletti James E
Sep/Oct 2004
Pg. 345-352

Featured Excipient: Plasticizers
Allen Loyd V Jr
Mar/Apr 2003
Pg. 145-148

Citric Acid, Potassium Citrate, and Sodium Citrate Solution
Allen Loyd V Jr
Jul/Aug 2011
Pg. 335

Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 156

Sufentanil Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 340

Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 245

Sildenafil Citrate 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 306

Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 69

Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha
, Harger Beau, Estrada Nick
Jul/Aug 2016
Pg. 277-280

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
Jan/Feb 2018
Pg. 57

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Return to Top